CHHE Stock Overview
Through its subsidiaries, manufactures and sells health products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
China Health Industries Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.33 |
52 Week High | US$3.00 |
52 Week Low | US$0.17 |
Beta | -20.71 |
11 Month Change | 0% |
3 Month Change | -68.45% |
1 Year Change | -78.33% |
33 Year Change | 30.00% |
5 Year Change | -35.00% |
Change since IPO | 225.00% |
Recent News & Updates
Recent updates
Shareholder Returns
CHHE | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | -1.1% | 1.0% |
1Y | -78.3% | -8.4% | 33.6% |
Return vs Industry: CHHE underperformed the US Personal Products industry which returned -9.4% over the past year.
Return vs Market: CHHE underperformed the US Market which returned 31.9% over the past year.
Price Volatility
CHHE volatility | |
---|---|
CHHE Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 14.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CHHE's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CHHE's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 33 | Sun Xin | www.chinahealthindustries.com |
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds.
China Health Industries Holdings, Inc. Fundamentals Summary
CHHE fundamental statistics | |
---|---|
Market cap | US$21.30m |
Earnings (TTM) | -US$1.36m |
Revenue (TTM) | US$95.95k |
222.0x
P/S Ratio-15.6x
P/E RatioIs CHHE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CHHE income statement (TTM) | |
---|---|
Revenue | US$95.95k |
Cost of Revenue | US$101.06k |
Gross Profit | -US$5.12k |
Other Expenses | US$1.36m |
Earnings | -US$1.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.021 |
Gross Margin | -5.33% |
Net Profit Margin | -1,419.55% |
Debt/Equity Ratio | -230.9% |
How did CHHE perform over the long term?
See historical performance and comparison